DEC 30, 2016 1:47 PM PST

Male Contraception Candidate Drug may Also Shrink Testicular Tumor

WRITTEN BY: Xuan Pham

An experimental drug that was originally intended to work for male contraception may also work to shrink testicular cancer.

The drug is a small-molecule inhibitor by the name of JQ1. Instead of working to influence changes at the DNA level, JQ1 affects changes at the epigenetic level. In particular, this drug interferes with protein binding at the bromodomain - a stretch of amino acids that “reads” certain chemical tags on histones.

"JQ1 inhibits those proteins that read these histone marks and thus changes the gene activity in the cell," explained Hubert Schorle from the Institute for Pathology at the University of Bonn, and the study’s senior author.

Previously, researchers showed that JQ1 inhibited an essential part of sperm development. Treatment of this drug in mice led to smaller testes, sperm count and motility. As such, it was considered for the part of a male contraceptive drug.

In studying the mechanisms of JQ1’s actions, researcher at the University of Bonn realized that the molecule could also influence testicular cancer development. JQ1 appears to inhibit bromodomain and extraterminal (BET) proteins, which in testicular cancer, triggers cellular stress signals and cause the cell to die.

"In a testicular cancer mouse model, the tumors began to shrink after administering JQ1," said Sina Jostes, the study’s lead author. "In contrast, healthy skin cells seem to tolerate JQ1 very well." The team showed positive tumor shrinkage in both cell culture and live animal models.

Jostes and colleagues also tested the effects of JQ1 alongside another histone deacetylase inhibitor known as romidepsin. This drug has previously been tested and approved for testicular cancer. However, the team reported that the combination of JQ1 and romidepsin seemed to have the greatest effect, especially in cancer types that proved resistant to therapy.

"In our study, we treated mice with both JQ1 and romidepsin," said Daniel Nettersheim, the study’s co-author. "This way, we achieved a similar effect alike JQ1 or romidepsin treatment alone, but we could reduce the quantities of both substances. Such a combination therapy to treat testicular tumors may be much better tolerated. Chemotherapy-resistant patients could also benefit from this."

Both the anticancer effects and the contraceptive effects of JQ1 are under further investigation.

Additional source:  University of Bonn

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 07, 2020
Cancer
Newly identified biomarker sheds light on antiangiogenic drug responses
NOV 07, 2020
Newly identified biomarker sheds light on antiangiogenic drug responses
A study published last week in the journal EMBO Molecular Medicine provides insight into the molecular mechanisms t ...
NOV 12, 2020
Immunology
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
NOV 12, 2020
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
Nutrition is essential to health; what we eat in our daily diet affects our overall health condition and what diseases w ...
DEC 07, 2020
Cancer
Can Cannabidiol inhibit head and neck cancer growth?
DEC 07, 2020
Can Cannabidiol inhibit head and neck cancer growth?
The usefulness of marijuana against cancer has been in question for some years now. Some are saying it has the potential ...
JAN 11, 2021
Cancer
Sentinel Nodes Could Reveal a Tumor's Prognosis
JAN 11, 2021
Sentinel Nodes Could Reveal a Tumor's Prognosis
For many diseases, the ability to quickly and effectively diagnose or prognose a patient is critical. If caught early on ...
JAN 14, 2021
Clinical & Molecular DX
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
JAN 14, 2021
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
  Only 10 percent of icebergs are visible on the surface of the water; the remaining 90 percent remains submerged. ...
JAN 20, 2021
Genetics & Genomics
Mutations in One Gene Can Lead to Cancer in Different Ways
JAN 20, 2021
Mutations in One Gene Can Lead to Cancer in Different Ways
Cancer and genetics are linked; for example, when a cell's genome accumulates mutations it can begin to divide uncon ...
Loading Comments...